Joanne Kurtzberg, MD
19
1
1
13
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
15.8%
3 terminated/withdrawn out of 19 trials
81.3%
-5.3% vs industry average
0%
0 trials in Phase 3/4
46%
6 of 13 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
A Randomized Study of Autologous Umbilical Cord Blood Reinfusion in Children With Cerebral Palsy
Role: lead
Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries
Role: lead
Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis
Role: lead
Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants
Role: lead
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
Role: lead
hCT-MSC Infusion in Adults With Autism Spectrum Disorder
Role: lead
Study of hCT-MSC in Newborn Infants With Moderate or Severe HIE
Role: lead
hCT-MSC in Children With Autism Spectrum Disorder
Role: lead
hCT-MSCs for COVID19 ARDS
Role: lead
Study of Allogeneic Umbilical Cord Blood Infusion for Adults With Ischemic Stroke
Role: lead
Infusions of Mesenchymal Stromal Cells in Children With Multisystem Inflammatory Syndrome
Role: lead
A Study of UCB and MSCs in Children With CP: ACCeNT-CP
Role: lead
Cord Blood Infusion for Children With Autism Spectrum Disorder
Role: lead
Assessment of the Safety of Allogeneic Umbilical Cord Blood Infusions in Children With Cerebral Palsy
Role: lead
hCT-MSCs for Children With Autism Spectrum Disorder (ASD)
Role: lead
Cord Blood Infusion for Ischemic Stroke
Role: lead
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells
Role: lead
Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases
Role: lead
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies
Role: lead
All 19 trials loaded